Dramatic reduction in GM crop trials

New EU report reveals drop in number of field-based trials of genetically modified crops.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The state of play in research and development on genetically modified organisms (GMOs) in the European Union (EU) is comprehensively assessed in a new report from the European Science and Technology Observatory. The report, undertaken for the European Commission, addresses one key question: "Which agricultural GM plants are most likely to be developed up to the market level in the next decade?"

The report reveals one dramatic finding: the number of field-based trials of GM crops in the EU has fallen by almost 80% since 1998. One important reason for this startling drop is the current web of legal uncertainties and confusion surrounding the development of GMOs. Different member states have different legislation, which is subject to differing interpretations.

And on April 10 the European Commission had to formally notify 12 member states that they have missed the deadline for transposing new EU legislation into national law. The EU Moratorium ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Andrew Scott

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo